Captrust Financial Advisors Rigel Pharmaceuticals Inc Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$0.67 - $3.19 $38 - $185	-58 Reduced 5.08%	1,084 $1,000
Q1 2022 May 16, 2022	BUY	$2.22 - $3.45 $2,266 - $3,522	1,021 Added 843.8%	1,142 $3,000
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $821 - $1,242	-348 Reduced 74.2%	121 $0
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $1,571 - $2,312	469 New	469 $2,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.